September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack. The findings were presented at the American Society for Radiation Oncology (ASTRO) meeting, Sept. 25-28 in Boston.

LifePak, AED, sudden cardiac arrest, defibrillator, automatic external defibrillator
zoll, lifevest, wearable defibrillator

Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock through the chest to the heart to bring irregular rhythm of the heart back to normal in patients with sudden cardiac arrest (SCA). In addition, AEDs help in detecting and identifying life-threatening arrhythmias. Almost 95 percent of patients with SCA die within a minute, which has led to increase in the demand for AEDs. 
TCT 2016, TCT.16, main arena, late breaking trials

September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first report investigation presentions at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 scientific symposium. The interventional cardiovascular medicine conference took place Oct. 29 – Nov. 2, 2016, in Washington, D.C.

Sunday, Oct. 30

Late-Breaking Trials: 

Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S. Department of Veterans Affairs (VA). The award establishes terms under which VA hospitals across the country may acquire Avinger’s Lumivascular portfolio of optical coherence tomography (OCT) image-guided catheters for their veterans hospitals.

In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the release of the supplement to its ninth annual EHRA White Book, developed in partnership with Biotronik. The supplement was released just ahead of the 2016 European Society of Cardiology (ESC) Congress, Aug. 27-31 in Rome.

BioTelemetry Inc. announced in late August that the company has received CE mark approval of its Holter analysis software.  The software can be used either on a stand-alone basis or in combination with the company’s family of digital Holter recorders.

Nearly 2 out of 5 people with diabetes who could benefit from statin therapy to lower their risk of future heart attack, stroke and related death were not prescribed one, according to a research letter published in the Journal of the American College of Cardiology. The analysis also showed wide variation in statin use across cardiology practices included in the study.

C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint to a six-month time point for the Lutonix 014 Drug Coated Balloon PTA Catheter (DCB). The Lutonix 014 device is currently the only DCB in an IDE clinical trial in the United States for treatment of arteries below the knee (BTK).

Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for heart attack patients to get lifesaving treatment after a hospital transfer, according to a research letter published in the Journal of the American College of Cardiology.

A Google search for heart conditions will now prominently display important questions patients should ask their doctor based on clinical guidelines developed by the American College of Cardiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now